by Lisa Rapaport
As of 2017, 66% of women were aware that dense breast tissue is associated with an increased risk of cancer, up from about 59% in 2012, researchers report in the Journal of the American College of Radiology…“The discussion was more often initiated by the healthcare provider than the (patient), regardless of whether the (patient) reported having dense breasts,” lead study author Dr. Deborah Rhodes of the Mayo Clinic in Rochester, Minnesota, and colleagues write. “Among those who reported having dense breasts, the source of this information was most commonly the healthcare provider who ordered the mammogram,” they note.
Reach: Reuters offers 24-hour coverage of global happenings for professionals around the world. With 196 editorial bureaus in 130 countries and 2,400 editorial staff members, it covers international news, regional news, politics, social issues, health, business, sports and media.
Additional coverage: Physician’s Weekly, KFGO-Radio, National Post
Context: Deborah Rhodes, M.D. is an internal medicine specialist from the Breast Diagnostic Clinic at Mayo Clinic. Dr. Rhodes studies the application of a new breast imaging device, molecular breast imaging, to breast cancer screening. The long-term goal of Dr. Rhodes' research is to develop an individualized approach to breast cancer screening that incorporates breast density, age, and other factors that impact breast cancer risk and mammography sensitivity. You can read more about the study here.
Contact: Joe Dangor
Tags: breast density, Dr. Deborah Rhodes, mammography, Reuters, Uncategorized